Priscilla Ortega
Medical · McAllen, TXNPI 1598834889
Payments from drug & device makers
Across 355 payments — averaging $21.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$3K
- Neurelis, Inc.$2K
- Jazz Pharmaceuticals Inc.$718
- Corium, LLC$357
- Sumitomo Pharma America, Inc.$353
- Eisai Inc.$312
- plus $1K from 23 others
What the payments were for
- Food & beverage$7,490100%
- Education$230%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 122 | $2,722 |
| Neurelis, Inc. | 56 | $1,573 |
| Jazz Pharmaceuticals Inc. | 27 | $718 |
| Corium, LLC | 19 | $357 |
| Sumitomo Pharma America, Inc. | 35 | $353 |
| Eisai Inc. | 18 | $312 |
| Otter Pharmaceuticals, LLC | 9 | $272 |
| Zogenix Inc. | 9 | $165 |
| Supernus Pharmaceuticals, Inc. | 8 | $163 |
| Sunovion Pharmaceuticals Inc. | 19 | $162 |
| SK Life Science, Inc. | 6 | $153 |
| Collegium Pharmaceutical, Inc. | 4 | $71 |
| Greenwich Biosciences, Inc. | 2 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $46 |
| Immedica Pharma US, Inc. | 2 | $46 |
| Acadia Pharmaceuticals Inc | 2 | $43 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
| ITF Therapeutics LLC | 1 | $34 |
| Livanova USA, Inc. | 1 | $33 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| Pyros Pharmaceuticals, Inc. | 1 | $23 |
| Sanofi | 1 | $23 |
| Catalyst Pharmaceuticals, Inc. | 1 | $22 |
| Genentech USA, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Sarepta Therapeutics, Inc. | 1 | $18 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| Biomarin Pharmaceutical Inc. | 1 | $14 |
| Tris Pharma Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Fintepla$230
How this compares
$7,513 in reported general payments places this provider in the 90th percentile of 1,490 medical providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levocarnitine | 13 | $502 |
Paid to pharmacies, not to this prescriber.
Other medical in McAllen
- Jason HenslerMcAllen$66K
- Edgar GarciaMcAllen$17K
- Claudia MaldonadoMcAllen$15K
- Rolando VelazquezMcAllen$13K
- Jose de la CerdaSan Antonio$1.1M
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.